Unknown

Dataset Information

0

Testing COVID-19 therapies to prevent progression of mild disease.

ABSTRACT:

SUBMITTER: Lipsitch M 

PROVIDER: S-EPMC7202831 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Testing COVID-19 therapies to prevent progression of mild disease.

Lipsitch Marc M   Perlman Stanley S   Waldor Matthew K MK  

The Lancet. Infectious diseases 20200506 12

Similar Datasets

Unknown Antibody therapies to prevent and treat COVID‐19
| S-EPMC9111079 | biostudies-literature
Genomics Human gut microbiota, COVID-19 patients with mild or severe symptoms.
2022-09-22 | E-MTAB-12236 | biostudies-arrayexpress
Transcriptomics Temporal dynamics of the host molecular responses underlying severe COVID-19 progression and disease resolution
2020-12-31 | E-MTAB-9721 | biostudies-arrayexpress
Unknown Effectiveness of Regdanvimab Treatment in High-Risk COVID-19 Patients to Prevent Progression to Severe Disease.
| S-EPMC8657590 | biostudies-literature
Unknown COVID-19 and MS disease-modifying therapies.
| S-EPMC7238896 | biostudies-literature
Unknown Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients.
| S-EPMC8757570 | biostudies-literature
Unknown Higher Dose Anticoagulation Cannot Prevent Disease Progression in COVID-19 Patients: A Systematic Review and Meta-Analysis.
| S-EPMC9496532 | biostudies-literature
Proteomics Discovery and systematic assessment of early biomarkers that predict progression to severe COVID-19 disease - 2nd cohort
2023-03-15 | E-MTAB-12777 | biostudies-arrayexpress
Proteomics Discovery and systematic assessment of early biomarkers that predict progression to severe COVID-19 disease - 1st cohort
2023-04-11 | E-MTAB-12779 | biostudies-arrayexpress
Unknown Targeting thromboinflammation in COVID-19 - A narrative review of the potential of C1 inhibitor to prevent disease progression.
| S-EPMC9393183 | biostudies-literature